AAAAAA
Results:
1-15
|
Results: 15
Authors:
SARBIA M
STABL M
ZURHAUSEN A
ZIMMERMANN K
WANG LH
FINK U
HEEP H
DUTKOWSKI P
WILLERS R
MULLER W
SEEBER S
GABBERT HE
Citation: M. Sarbia et al., EXPRESSION OF P21(WAF1) PREDICTS OUTCOME OF ESOPHAGEAL CANCER-PATIENTS TREATED BY SURGERY ALONE OR BY COMBINED THERAPY MODALITIES, Clinical cancer research, 4(11), 1998, pp. 2615-2623
Authors:
AMREIN R
STABL M
HENAUER S
AFFOLTER E
JONKANSKI I
Citation: R. Amrein et al., EFFICACY AND TOLERABILITY OF MOCLOBEMIDE IN COMPARISON WITH PLACEBO, TRICYCLIC ANTIDEPRESSANTS, AND SELECTIVE SEROTONIN REUPTAKE INHIBITORSIN ELDERLY DEPRESSED-PATIENTS - A CLINICAL OVERVIEW, Canadian journal of psychiatry, 42(10), 1997, pp. 1043-1050
Authors:
VERSIANI M
AMREIN R
STABL M",MAGISTRIS,"UDABE RU
DACOSTA DA
NARDI AE
CAPPONI R
Citation: M. Versiani et al., MOCLOBEMIDE AND IMIPRAMINE IN CHRONIC DEPRESSION (DYSTHYMIA) - AN INTERNATIONAL DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, International clinical psychopharmacology, 12(4), 1997, pp. 183-193
Authors:
DINGEMANSE J
GUENTERT T
GIESCHKE R
STABL M
Citation: J. Dingemanse et al., MODIFICATION OF THE CARDIOVASCULAR EFFECTS OF EPHEDRINE BY THE REVERSIBLE MONOAMINE-OXIDASE-A INHIBITOR MOCLOBEMIDE, Journal of cardiovascular pharmacology, 28(6), 1996, pp. 856-861
Authors:
EAP CB
GUENTERT TW
SCHAUBLINLOIDL M
STABL M
KOEB L
POWELL K
BAUMANN P
Citation: Cb. Eap et al., PLASMA-LEVELS OF THE ENANTIOMERS OF THIORIDAZINE, THIORIDAZINE 2-SULFOXIDE, THIORIDAZINE 2-SULFONE, AND THIORIDAZINE 5-SULFOXIDE IN POOR AND EXTENSIVE METABOLIZERS OF DEXTROMETHORPHAN AND MEPHENYTOIN, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 322-331
Authors:
ANGST J
AMREIN R
STABL M
Citation: J. Angst et al., MOCLOBEMIDE AND TRICYCLIC ANTIDEPRESSANTS IN SEVERE DEPRESSION - METAANALYSIS AND PROSPECTIVE STUDIES, Journal of clinical psychopharmacology, 15(4), 1995, pp. 16-23
Authors:
STABL M
KASAS A
BLAJEV B
BAJETTA G
ZOCHLING R
HOLSBOERTRACHSLER E
REALINI R
SCHAUBLINLOIDL M
Citation: M. Stabl et al., A DOUBLE-BLIND COMPARISON OF MOCLOBEMIDE AND THIORIDAZINE VERSUS MOCLOBEMIDE AND PLACEBO IN THE TREATMENT OF REFRACTORY, SEVERE DEPRESSION, Journal of clinical psychopharmacology, 15(4), 1995, pp. 41-45
Authors:
AKISKAL HS
SILVA JACE
FRANCES A
FREEMAN HL
KELLER MB
LAPIERRE YD
IBOR JJL
PAYKEL ES
STABL M
Citation: Hs. Akiskal et al., DYSTHYMIA IN CLINICAL-PRACTICE, British Journal of Psychiatry, 166, 1995, pp. 174-183
Authors:
LECRUBIER Y
PEDARRIOSSE AM
PAYAN C
SCHMIDBURGK W
STABL M
Citation: Y. Lecrubier et al., MOCLOBEMIDE VERSUS CLOMIPRAMINE IN NONMELANCHOLIC, NONPSYCHOTIC MAJORDEPRESSION, Acta psychiatrica Scandinavica, 92(4), 1995, pp. 260-265
Authors:
MOLL E
NEUMANN N
SCHMIDBURGK W
STABL M
AMREIN R
Citation: E. Moll et al., SAFETY AND EFFICACY DURING LONG-TERM TREATMENT WITH MOCLOBEMIDE, Clinical neuropharmacology, 17, 1994, pp. 190000074-190000087
Authors:
WARDLE J
HAYWARD P
HIGGITT A
STABL M
BLIZARD R
GRAY J
Citation: J. Wardle et al., EFFECTS OF CONCURRENT DIAZEPAM TREATMENT ON THE OUTCOME OF EXPOSURE THERAPY IN AGORAPHOBIA, Behaviour research and therapy, 32(2), 1994, pp. 203-215
Authors:
KELLER MB
STABL M
Citation: Mb. Keller et M. Stabl, DYSTHYMIA IN CLINICAL-PRACTICE - CONCLUDING REMARKS, Acta psychiatrica Scandinavica, 89, 1994, pp. 49-50
Authors:
ANGST J
DELINISTULA A
STABL M
STASSEN HH
Citation: J. Angst et al., IS A CUTOFF SCORE A SUITABLE MEASURE OF TREATMENT OUTCOME IN SHORT-TERM TRIALS IN DEPRESSION - A METHODOLOGICAL METAANALYSIS, Human psychopharmacology, 8(5), 1993, pp. 311-317
Authors:
ANGST J
SCHEIDEGGER P
STABL M
Citation: J. Angst et al., EFFICACY OF MOCLOBEMIDE IN DIFFERENT PATIENT GROUPS - RESULTS OF NEW SUBSCALES OF THE HAMILTON DEPRESSION RATING-SCALE, Clinical neuropharmacology, 16, 1993, pp. 190000055-190000062
Authors:
HEINZE G
ROSSEL L
GABELIC I
GALEANOMUNOZ J
STABL M
ALLEN SR
Citation: G. Heinze et al., DOUBLE-BLIND COMPARISON OF MOCLOBEMIDE AND TRANYLCYPROMINE IN DEPRESSION, Pharmacopsychiatry, 26(6), 1993, pp. 240-245
Risultati:
1-15
|